A Clinical Trial to Investigate the Safety and Efficacy of MB-1 on Metabolic Health in Overweight and Obese Adults

NCT07363148 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-01-26

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate the safety and efficacy of MB-1 on metabolic health in overweight and obese adults. The main question it aims to answer is:

What is the difference in change in body weight and body mass index (BMI) from baseline at Day 84 between MB-1 and placebo?

Participants will be provided MB-1 or placebo and be assessed for anthropometric measurements, blood pressure, heart rate, and asked to complete appetite and satiety questionnaires and undergo a DEXA scan.

Conditions

Obese
Overweight Adults
Obese Adults
Body Weight Control
BMI

Interventions

DIETARY_SUPPLEMENT

MB-1

Participants will be instructed to take two capsules every morning with a meal for the duration of the study starting on Day 1.

OTHER

Placebo

Participants will be instructed to take two capsules every morning with a meal for the duration of the study starting on Day 1.

Sponsors & Collaborators

KGK Science Inc.
collaborator INDUSTRY
Arrae
lead INDUSTRY

Principal Investigators

David Crowley, MD · KGK Science Inc.

Study Design

Allocation: RANDOMIZED
Purpose: TREATMENT
Masking: TRIPLE
Model: PARALLEL

Eligibility

Min Age: 18 Years
Max Age: 65 Years
Sex: ALL
Healthy Volunteers: No

Timeline & Regulatory

Start: 2026-04-30
Primary Completion: 2026-04-30
Completion: 2026-07-31

Countries

Canada

Study Locations

More Related Trials

Entities

Diseases

Obese